Vulnerable Subjects Clause Samples

The 'Vulnerable Subjects' clause defines how individuals who may be at increased risk or have diminished capacity—such as children, the elderly, or those with cognitive impairments—are identified and protected within the context of an agreement or research protocol. This clause typically outlines additional safeguards, consent requirements, or oversight measures that must be implemented when engaging with these populations. Its core function is to ensure that vulnerable individuals are not exploited or exposed to undue risk, thereby upholding ethical standards and legal compliance.
Vulnerable Subjects. Vulnerable subjects will not be enrolled.
Vulnerable Subjects. OCSO agrees to develop and implement an ECW policy that prohibits, absent exigent circumstances, deployment of the ECW against the following subjects, or under the following circumstances: (1) in an environment where the subject’s fall may cause substantial injury or death (e.g., an elevated location such as rooftop or building ledge; standing in or near water or other drowning hazards; or climbing a fence or wall); (2) against a subject in physical control of a vehicle in motion, including a bicycle; (3) against an apparently helpless person or an individual with an apparent severe disability; (4) against a reasonably apparent young child; (5) against a reasonably apparent elderly person; (6) against a female person reasonably believed to be pregnant; (7) within an elementary school.
Vulnerable Subjects. Certain populations are considered to be vulnerable and require special protections when asked to participate in a research study. (Vulnerable populations include, but are not limited to pregnant women, fetuses, human embryos, prisoners, children, and cognitively impaired individuals or persons with questionable capacity to consent. Others which may require special consideration include elderly persons, economically disadvantaged persons and educationally disadvantaged persons.) Children include all persons who have not attained the legal age for consent to treatments or procedures involved in the research under the applicable law of the jurisdiction in which the research will be conducted (the age of majority is 18 years in the Connecticut). Parental permission and the child's assent is required for participation in the study. (Assent is defined as "a child's affirmative agreement to participate in research" and should be sought in addition to parental permission when the minor subject is sufficiently mature to understand the nature of his or her participation in a research study.) Please refer to the HIC Guidelines for Investigators at http://www.med.yale.edu/▇▇▇/▇▇▇▇▇/▇▇▇▇▇/▇▇▇▇▇▇▇▇▇▇.pdf Will vulnerable subjects be enrolled in the study? If so, identify the vulnerable population and provide a justification for their involvement. Also address any additional safeguards necessary to protect the rights and welfare of vulnerable subjects. No

Related to Vulnerable Subjects

  • Data Subjects The categories of Data Subjects who we may collect Personal Data about may include the following where they are a natural person: the Customer, the directors and ultimate beneficial owner(s) of the Customer, your customers, employees and contractors, payers and payees. You may share with Airwallex some or all of the following types of Personal Data regarding Data Subjects: • full name; • email address; • phone number and other contact information; • date of birth; • nationality; • public information about the data subject; • other relevant verification or due diligence documentation as required under these terms; and • any other data that is necessary or relevant to carry out the Agreed Purposes.

  • Safeguarding and Protecting Children and Vulnerable Adults The Supplier will comply with all applicable legislation and codes of practice, including, where applicable, all legislation and statutory guidance relevant to the safeguarding and protection of children and vulnerable adults and with the British Council’s Child Protection Policy, as notified to the Supplier and amended from time to time, which the Supplier acknowledges may include submitting to a check by the UK Disclosure & Barring Service (DBS) or the equivalent local service; in addition, the Supplier will ensure that, where it engages any other party to supply any of the Services under this Agreement, that that party will also comply with the same requirements as if they were a party to this Agreement.

  • Infectious Disease The Employer shall provide Bargaining Unit Employees with information about residents' infectious diseases provided that such information does not compromise HIPAA or otherwise infringe upon residents' rights to confidentiality.

  • Infectious Diseases The Employer and the Union desire to arrest the spread of infectious diseases in the nursing home. To achieve this objective, the Joint Health and Safety Committee may review and offer input into infection control programs and protocols including surveillance, outbreak control, isolation, precautions, worker education and training, and personal protective equipment. The Employer will provide training and ongoing education in communicable disease recognition, use of personal protective equipment, decontamination of equipment, and disposal of hazardous waste.

  • Third Party Sites The Platform may provide links to third-party web sites. Third parties and third party web sites may have different privacy policies, terms and conditions and business practices than we do. Your dealings or communications with any party other than the Company are solely between you and that third party. Reference on the Site to any product, process, publication or service of any third party by trade name, domain name, trademark, trade identity, service ▇▇▇▇, logo, and manufacturer or otherwise does not constitute or imply its endorsement or recommendation by the Company.